These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3175971)
1. Management and outcome of pulmonary tuberculosis in adults notified in England and Wales in 1983. Medical Research Council Tuberculosis and Chest Diseases Unit. Thorax; 1988 Aug; 43(8):591-8. PubMed ID: 3175971 [TBL] [Abstract][Full Text] [Related]
2. Management and outcome of chemotherapy for childhood tuberculosis. Medical Research Council Tuberculosis and Chest Diseases Unit. Arch Dis Child; 1989 Jul; 64(7):1004-12. PubMed ID: 2629621 [TBL] [Abstract][Full Text] [Related]
3. Treatment of pulmonary tuberculosis in patients notified in England and Wales in 1978-9: chemotherapy and hospital admission. Medical Research Council Tuberculosis and Chest Diseases Unit. Thorax; 1985 Feb; 40(2):113-20. PubMed ID: 3975862 [TBL] [Abstract][Full Text] [Related]
4. The management of pulmonary tuberculosis in adults notified in England and Wales in 1988. The British Thoracic Society Research Committee and the Medical Research Council Cardiothoracic Epidemiology Group. Respir Med; 1991 Jul; 85(4):319-23. PubMed ID: 1947370 [TBL] [Abstract][Full Text] [Related]
5. Short-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens of 28 and 36 weeks duration in Algeria. Algerian Working Group/British Medical Research Council Cooperative Study. Tubercle; 1991 Jun; 72(2):88-100. PubMed ID: 1949222 [TBL] [Abstract][Full Text] [Related]
6. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients]. Wada M Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781 [TBL] [Abstract][Full Text] [Related]
7. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study. Am Rev Respir Dis; 1984 Jun; 129(6):921-8. PubMed ID: 6375490 [TBL] [Abstract][Full Text] [Related]
8. National survey of tuberculosis notifications in England and Wales in 1983: characteristics of disease. Report from the Medical Research Council Tuberculosis and Chest Diseases Unit. Tubercle; 1987 Mar; 68(1):19-32. PubMed ID: 3116730 [TBL] [Abstract][Full Text] [Related]
9. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
10. Deaths occurring in newly notified patients with pulmonary tuberculosis in England and Wales. Humphries MJ; Byfield SP; Darbyshire JH; Davies PD; Nunn AJ; Citron KM; Fox W Br J Dis Chest; 1984 Apr; 78(2):149-58. PubMed ID: 6722018 [TBL] [Abstract][Full Text] [Related]
11. Tuberculosis in England and Wales in 1993: results of a national survey. Public Health Laboratory Service/British Thoracic Society/Department of Health Collaborative Group. Kumar D; Watson JM; Charlett A; Nicholas S; Darbyshire JH Thorax; 1997 Dec; 52(12):1060-7. PubMed ID: 9516900 [TBL] [Abstract][Full Text] [Related]
13. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association. Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175 [TBL] [Abstract][Full Text] [Related]
14. Ultrashort-course chemotherapy for culture-negative pulmonary tuberculosis--a qualified success. Cowie RL; Langton ME; Escreet BC S Afr Med J; 1985 Dec; 68(12):879-80. PubMed ID: 4071345 [TBL] [Abstract][Full Text] [Related]
15. Short-course chemotherapy for isoniazid-resistant pulmonary tuberculosis. Bai KJ; Yu MC; Suo J; Chiang CY; Chiang IH; Lin TP; Luh KT J Formos Med Assoc; 1998 Apr; 97(4):278-82. PubMed ID: 9585680 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of a 6-month chemotherapy and a l2-month chemotherapy in the treatment of pulmonary tuberculosis in Algerian Sahara. Cooperative study by an Algerian work team and the British Medical Research Council]. Chaulet P Bull Int Union Tuberc; 1985; 60(1-2):31-3. PubMed ID: 4074970 [No Abstract] [Full Text] [Related]
17. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119 [TBL] [Abstract][Full Text] [Related]
18. National survey of tuberculosis notifications in England and Wales 1978--9. Report from the Medical Research Council Tuberculosis and Chest Diseases Unit. Br Med J; 1980 Oct; 281(6245):895-8. PubMed ID: 7427500 [TBL] [Abstract][Full Text] [Related]
19. National survey of notifications of tuberculosis in England and Wales in 1988. Medical Research Council Cardiothoracic Epidemiology Group. Thorax; 1992 Oct; 47(10):770-5. PubMed ID: 1481174 [TBL] [Abstract][Full Text] [Related]
20. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years]. Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]